Stockreport

Fulcrum Therapeutics Upgraded: BofA Debates Pivotal Study Success For Losmapimod In Rare Genetic Muscle Disease [Yahoo! Finance]

Avidity Biosciences, Inc.  (RNA) 
PDF FSHD is a rare genetic muscle disease affecting a child's facial muscles, shoulders, upper arms, and lower legs. These muscles weaken and shrink (atrophy). The analys [Read more]